Market Research Logo

Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

Osteoarthritis Therapeutics Market by Anatomy (Knee, Hip), Drug Type (NSAIDs, Corticosteroids), Route of Administration (Parenteral, Topical), Distribution Channel (Hospital Pharmacies), Purchasing Pattern (Prescription Drugs) - Global Forecast to 2024

“The osteoarthritis therapeutics market is projected to register a CAGR of 8.1% during the forecast period.”
The osteoarthritis therapeutics market is projected to reach USD 10.1 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 8.1%. Growth in this industry is driven by the rapid growth in the geriatric and obese population and the associated increase in the prevalence of osteoarthritis disease. On the other hand, the availability of alternative non-drug pain management therapies is a major market challenge.

“Knee osteoarthritis segment to witness the highest growth during the forecast period.”
Based on anatomy, the osteoarthritis therapeutics market is segmented into knee, hip, hand, and small-joint. The knee osteoarthritis segment is projected to grow at the highest CAGR during the forecast period. A large number of patients suffering from knee osteoarthritis is the major factor supporting the growth of this segment.

“Viscosupplementation agents segment to register the highest growth in the osteoarthritis therapeutics market during the forecast period.”
Based on drug type, the osteoarthritis therapeutics market is segmented into viscosupplementation agents, nonsteroidal anti-inflammatory drugs (NSAIDs), analgesics, and corticosteroids. The analgesics segment is sub-segmented into duloxetine and acetaminophen, while the NSAIDs segment is sub-segmented into naproxen, aspirin, diclofenac, ibuprofen, and other molecules. The viscosupplementation agents segment is projected to witness the highest growth in the osteoarthritis therapeutics market during the forecast period. The rising incidence of knee osteoarthritis is one of the major factors supporting the growth of this segment.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the osteoarthritis therapeutics market is segmented into four major regional segments, namely, Europe, North America, Asia Pacific, and the Rest of the World (RoW). The market in Asia-Pacific is projected to register the highest growth rate during the forecast period. The growth in this market is driven primarily by the rising incidence and prevalence of osteoarthritis, increasing geriatric and obese populations, and healthcare infrastructure improvements in several APAC countries.

Breakdown of Profiles of Primary Participants:
By Company Type: Tier 1: 20%, Tier 2: 45%, and Tier 3: 35%
By Designation: C-level: 30%, Director-level: 20%, and Others: 50%
By Region: North America: 35%, Europe: 24%, Asia Pacific: 25%, and the Rest of the World: 16%

Key players in the osteoarthritis therapeutics market include Sanofi (France), Horizon Therapeutics (Ireland), Johnson & Johnson (US), GlaxoSmithKline Plc (UK), Bayer AG (Germany), Abbott (US), Pfizer (US), Eli Lilly (US), Anika Therapeutics (US), and Flexion Therapeutics (US).

Research Coverage:
The report analyzes the osteoarthritis therapeutics market by anatomy, drug type, route of administration, distribution channel, purchasing pattern, and region. Apart from comprehensive geographic product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by market players over the last three years. In addition, the company profiles include the product portfolios, developments, and strategies adopted by prominent market players to maintain and increase their shares in the market. Market research data, current market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the market.

Key Benefits of Buying the Report:
This report will enable both established firms and new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help these firms garner greater market shares. Firms purchasing the report can use any one, or a combination of the below mentioned five strategies for strengthening their market shares.

The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the osteoarthritis therapeutics market
Product Development/Innovation: Detailed insights on the product approvals, R&D activities, and product launches in the osteoarthritis therapeutics market
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the osteoarthritis therapeutics market
Market Development: Detailed information about emerging markets. The report analyzes the market for various osteoarthritis therapeutics across geographies
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the osteoarthritis therapeutics market


  • INTRODUCTION
    • OBJECTIVES OF THE STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • OSTEOARTHRITIS THERAPEUTICS MARKET OVERVIEW
    • EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY ANATOMY (2018)
    • GEOGRAPHICAL SNAPSHOT OF THE OSTEOARTHRITIS THERAPEUTICS MARKET
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
    • KNEE OSTEOARTHRITIS
      • RISING OBESE AND GERIATRIC POPULATIONS TO INCREASE THE PREVALENCE OF KNEE OSTEOARTHRITIS
        • Table KNEE OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • HIP OSTEOARTHRITIS
      • SIMILAR TO KNEE OSTEOARTHRITIS, HIP OSTEOARTHRITIS IS MORE COMMON IN THE GERIATRIC AND OBESE POPULATIONS
        • Table HIP OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • HAND OSTEOARTHRITIS
      • RISING PREVALENCE OF SHOULDER OSTEOARTHRITIS TO DRIVE MARKET GROWTH
        • Table HAND OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • SMALL-JOINT OSTEOARTHRITIS
      • RISING NUMBER OF ANKLE-RELATED SPORTS INJURIES TO INCREASE THE PREVALENCE OF ANKLE OSTEOARTHRITIS
        • Table SMALL-JOINT OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
    • VISCOSUPPLEMENTATION AGENTS
      • VISCOSUPPLEMENTATION AGENTS DOMINATED THE MARKET IN 2018
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR VISCOSUPPLEMENTATION AGENTS, BY REGION, 2017-2024 (USD MILLION)
    • NONSTEROIDAL ANTI-INFLAMMATORY DRUGS
      • NSAIDS CAN RELIEVE PAIN AND INFLAMMATION WITHOUT THE VARIOUS POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH CORTICOSTEROIDS
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR IBUPROFEN, BY REGION, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR DICLOFENAC, BY REGION, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ASPIRIN, BY REGION, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR NAPROXEN, BY REGION, 2017-2024 (USD MILLION)
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR OTHER MOLECULES, BY REGION, 2017-2024 (USD MILLION)
    • ANALGESICS
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY REGION, 2017-2024 (USD MILLION)
      • ACETAMINOPHEN
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ACETAMINOPHEN, BY REGION, 2017-2024 (USD MILLION)
      • DULOXETINE
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR DULOXETINE, BY REGION, 2017-2024 (USD MILLION)
    • CORTICOSTEROIDS
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR CORTICOSTEROIDS, BY REGION, 2017-2024 (USD MILLION)
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
    • ORAL ROUTE
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ORAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
    • PARENTERAL ROUTE
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR PARENTERAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
    • TOPICAL ROUTE
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR TOPICAL ROUTE OF ADMINISTRATION, BY REGION, 2017-2024 (USD MILLION)
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
    • HOSPITAL PHARMACIES
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2017-2024 (USD MILLION)
    • ONLINE PHARMACIES
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR ONLINE PHARMACIES, BY REGION, 2017-2024 (USD MILLION)
    • RETAIL PHARMACIES
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR RETAIL PHARMACIES, BY REGION, 2017-2024 (USD MILLION)
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
    • PRESCRIPTION DRUGS
      • PRESCRIPTION DRUGS TO ACCOUNT FOR A LARGER SHARE OF THE MARKET
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR PRESCRIPTION DRUGS, BY REGION, 2017-2024 (USD MILLION)
    • OVER-THE-COUNTER DRUGS
      • EASE OF PURCHASE AND ADMINISTRATION RESULTING IN A RISING DEMAND FOR OTC DRUGS
        • Table OSTEOARTHRITIS THERAPEUTICS MARKET FOR OVER-THE-COUNTER DRUGS, BY REGION, 2017-2024 (USD MILLION)
  • OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION
    • INTRODUCTION
      • Table OSTEOARTHRITIS THERAPEUTICS MARKET, BY REGION, 2017-2024 (USD MILLION)
    • EUROPE
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
      • Table EUROPE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • ITALY
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table ITALY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • GERMANY
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table GERMANY: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • SPAIN
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table SPAIN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • FRANCE
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table FRANCE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • UK
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table UK: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • REST OF EUROPE
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table ROE: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
      • Table NORTH AMERICA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • US
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table US: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • CANADA
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table CANADA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
      • Table ASIA PACIFIC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • JAPAN
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table JAPAN: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • CHINA
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table CHINA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • INDIA
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table INDIA: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
        • Table ROAPAC: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
    • REST OF THE WORLD
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ANATOMY, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DRUG TYPE, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET FOR ANALGESICS, BY TYPE, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET FOR NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY MOLECULE, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL, 2017-2024 (USD MILLION)
      • Table ROW: OSTEOARTHRITIS THERAPEUTICS MARKET, BY PURCHASING PATTERN, 2017-2024 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • MARKET RANKING ANALYSIS, 2018
    • COMPETITIVE SCENARIO
      • PRODUCT LAUNCHES AND APPROVALS, 2016-2019
      • COLLABORATIONS, 2016-2019
      • EXPANSIONS, 2016-2019
      • ACQUISITIONS, 2016-2019
      • OTHER DEVELOPMENTS
    • COMPETITIVE LEADERSHIP MAPPING
      • VENDOR INCLUSION CRITERIA
      • VISIONARY LEADERS
      • INNOVATORS
      • DYNAMIC DIFFERENTIATORS
      • EMERGING COMPANIES
  • COMPANY PROFILES
    • SANOFI
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • HORIZON THERAPEUTICS PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • JOHNSON & JOHNSON
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • GLAXOSMITHKLINE PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • BAYER AG
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ABBOTT
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • PFIZER, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • ELI LILLY
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • ELI LILLY: OSTEOARTHRITIS DRUGS PIPELINE
    • ANIKA THERAPEUTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • NOVARTIS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • FERRING PHARMACEUTICALS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • BIOVENTUS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ZIMMER BIOMET HOLDINGS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
    • FIDIA FARMACEUTICI S.P.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • FLEXION THERAPEUTICS, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • FLEXION THERAPEUTICS: OSTEOARTHRITIS DRUGS PIPELINE
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
    • AVAILABLE CUSTOMIZATIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook